Suche

Apremilast Accord

L04AA32

Otezla

apremilast · L04AA32

Plaque Psoriasis L40.0 Diagnostik, Differenzialdiagnostik & Therapie‑Standard

Plaque‑Psoriasis ist eine chronisch‑entzündliche Hauterkrankung, die durch erythematöse, schuppige Plaques gekennzeichnet ist. Die Prävalenz liegt in europäischen Populationen bei etwa 2 % und variiert nach Alter und Geschlecht leicht. Sie …

Otezla · 4.5 · In clinical studies, apremilast has been administered concomitantly with topical therapy (including corticoste

Otezla · 4.5 · There was no clinically meaningful interaction between ketoconazole and apremilast. Apremilast can be co-admin

Otezla · 4.5 · There was no pharmacokinetic interaction between apremilast and methotrexate in psoriatic arthritis patients.

Otezla · 4.5 · There was no pharmacokinetic interaction between apremilast and oral contraceptives containing ethinyl estradi

Otezla · 4.8 · Paediatric patients The safety of apremilast was assessed in a 52-week clinical trial in paediatric patients 6

Otezla · 4.8 · Patients with hepatic impairment The safety of apremilast was not evaluated in PsA, PSOR or BD patients with h

Real-world effectiveness and safety of apremilast in psoriatic arthritis: results from the multicenter Italian MAPSI II study

pubmed · 42247059

Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study

pubmed · 40767996

Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial

pubmed · 36300769

Treatment of Erythema Annulare Centrifugum-Like Parapsoriasis With Apremilast

pubmed · 42051104